
Diageo, China SXT Pharmaceuticals, and UP Fintech are the three Chinese stocks to watch today, according to MarketBeat’s stock screener tool. “Chinese stocks” refers to shares of publicly traded companies that are based in China or have significant business operations there. For stock market investors, the term can also include Chinese companies listed on domestic Chinese exchanges as well as those traded on foreign exchanges, such as U.S.-listed Chinese firms. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Diageo (DEO)
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.
China SXT Pharmaceuticals (SXTC)
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
Read Our Latest Research Report on SXTC
UP Fintech (TIGR)
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.
Read Our Latest Research Report on TIGR
Recommended Stories
- MarketBeat’s Top Five Stocks to Own in July 2026
- Otis Took Another Guidance Cut—But the Story Isn’t Over
- Is Buying a Launch Company AST SpaceMobile’s Next Vertical Integration Move?
- AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
- The 2026 Blueprint: 6 Stocks for a Brand New Portfolio
- Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken
